Member of the Board and Chairman since 2015
Professor Carl Borrebaeck, Chairman of the Board since 2015 and Member since 2010, is an entrepreneur who founded Immunovia AB, Senzagen AB, BioInvent International AB, Alligator BioScience AB and PainDrainer AB.
In 2009, Professor Borrebaeck was awarded AkzoNobel’s Science Prize; in 2012, he received the Gold Medal of the Royal Engineering Academy for his ground-breaking research on biomarkers and in 2017, he was appointed Biotech Builder of the year for his entrepreneurship. Professor Borrebaeck is a permanent member of the IVA (Engineering Academy), Director of CREATE Health Strategic Center for Translational Cancer Research, and former Vice-Principal at Lund University. Carl Borrebaeck is also the Founding Mentor for NOME (Nordic Mentor Network for Entrepreneurship).
Current appointments: Chariman of SenzaGen AB, Immunovia AB and CB Ocean Capital AB. Board member of Alligator Bioscience AB, Qlucore AB and Scandion A/S. Partner in Immunova Handelsbolag.
Previous appointments (last five years): Chairman of LU Innovation System AB. Board member of Atlas Therapeutics AB, BioInvent International Aktiebolag, LU Holding AB, Medicon Village Fastighets AB, WntResearch AB and CLS AB.